HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct‐acting antivirals

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|25|1|72-79

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.25, Iss.1, 2018-01, pp. : 72-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct‐acting antiviral treatment for HCV

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 76-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

P151: Improvement of virologic response and liver elasticity in HCV‐patients after liver transplantation through treatment with the new direct‐acting antivirals

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 94-95

John Wiley & Sons Inc

Access to resources Recommend Favorite

Memory re‐differentiation and reduced lymphocyte activation in chronic HCV‐infected patients receiving direct‐acting antivirals

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 983-991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study

By  

Current Drug Safety, Vol. 13, Iss. 3, 2018-11 ,pp. : 187-195

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct‐acting anti‐virals

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 866-876

John Wiley & Sons Inc

Access to resources Recommend Favorite